Chemical Structure : PF-07104091
CAS No.: 2460249-19-6
Catalog No.: PC-20283Not For Human Use, Lab Use Only.
PF-07104091 (PF 07104091) is a highly potent CDK2-selective inhibitor with potential for the treatment of cyclinE-amplified cancers.
Packing | Price | Stock | Quantity |
---|---|---|---|
2 mg | $248 | In stock | |
5 mg | $398 | In stock | |
10 mg | $548 | In stock | |
25 mg | $858 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PF-07104091 (PF 07104091) is a highly potent CDK2-selective inhibitor with potential for the treatment of cyclinE-amplified cancers.
PF-07104091 displays 100-fold selectivity against CDK1, 200 to 400-fold selectivity against CDK4 and CDK6, 170-fold selectivity against CDK9, and greater than 500-fold selectivity against GSK3B.
PF-07104091 demonstrated a dose-dependent tumor growth reduction with 86 percent maximal effect in ovarian cancer model and demonstrated single-agent efficacy across multiple ovarian models.
M.Wt | 404.47 | |
Formula | C19H28N6O4 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(1R,3S)-3-(3-(3-(methoxymethyl)-1-methyl-1H-pyrazole-5-carboxamido)-1H-pyrazol-5-yl)cyclopentyl isopropylcarbamate |
1. Hoffman, R. L., PF-07104091: A CDK2 selective inhibitor of cyclinE amplified cancers. In AACR Annual Meeting 2021, Session DDT02.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright